Weight and Body Shape Changes in a Treatment-Naive Population after 6 Months of Nevirapine-Based Generic Highly Active Antiretroviral Therapy in South India

Abstract

The group that lost weight and the group whose weight remained stable experienced significant CD4+ T cell count increases at 6 months. Although the majority of HIV-infected patients who received nevirapine-based HAART gained weight, there were participants who lost weight despite initiating their first HAART therapy.